Discover how the combination of interferon and ribavirin revolutionized hepatitis C treatment for patients who failed initial interferon therapy.
Discover how interferon therapy is revolutionizing treatment for acquired pure red cell aplasia, a rare blood disorder where the body stops producing red blood cells.
Discover how hepatitis C virus stimulates murine CD8α-like dendritic cells to produce type I interferon in a TRIF-dependent manner, revealing new insights into antiviral immunity.